ArticleNeuro-oncology advances
Postsurgical detection of glioma recurrence using MRI radiomics.
Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In the postoperative setting, distinguishing between treatment-related changes and glioma recurrence remains a major challenge in neuroradiology. This pilot study explored a dedicated radiomics-based approach applied to postoperative MRI. Methods: We retrospectively analyzed postoperative MRI scans from 38 patients with diffuse adult-type gliomas treated at the University Hospital Zurich. Recurrence was confirmed histologically or by clinico-radiological consensus. New contrast-enhancing VOIs were manually delineated on T1c images, and corresponding radiomics features were extracted from T1c and FLAIR images and were aggregated across VOIs. Logistic regression models were trained and evaluated on repeated random splits, with feature importance assessed through univariable analyses and selection frequency across iterations. Results: Feature aggregation by minimum value (min) and selection by maximum volume (maxVol) produced significantly predictive models for both FLAIR- and T1c-derived features. Shape features achieved significantly predictive performance, with AUCs of 0.78 [0.70, 0.85] (FLAIR) and 0.76 [0.70, 0.81] (T1c) on internal testing. Among individual features, Shape Sphericity showed the highest discriminative ability, distinguishing recurrence with AUCs of 0.79 (maxVol aggregation) and 0.82 (min aggregation). Conclusion: We identified robust shape-based radiomics features on T1c imaging that were significantly predictive of glioma recurrence. Dominant features-including Sphericity, Volume, and Surface-to-Volume Ratio-were consistently selected in 70% to 100% of modeling repetitions. Pending prospective validation in larger multi-institutional cohorts, these findings may ultimately support more accurate clinical decision-making in postoperative glioma management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.